Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Intensity Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INTS.
You can purchase shares of Intensity Therapeutics (NASDAQ:INTS) through any online brokerage.
Other companies in Intensity Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Burning Rock Biotech (NASDAQ:BNR), Coeptis Therapeutics (NASDAQ:COEP), Armata Pharmaceuticals (AMEX:ARMP) and Barinthus Biotherapeutics (NASDAQ:BRNS).
Intensity Therapeutics has a consensus price target of $8.50.
The stock price for Intensity Therapeutics (NASDAQ: INTS) is $1.99 last updated April 11, 2025 at 8:33 AM EDT.
There are no upcoming dividends for Intensity Therapeutics.
Intensity Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Intensity Therapeutics.
Intensity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.